Table of Contents
1 Table Of Contents 2
1.1 List Of Tables 4
1.2 List Of Figures 7
2
Introduction 10
2.1 What is This Report About? 10
2.2 Methodology
10
2.3 Profile Of Survey Respondents 11
3 Executive Summary 15
4
Economic Outlook & Confidence 18
4.1 Global Economy Recovery Expectations
18
4.2 Revenue Growth Expectations 22
5 Drug Manufacturing Industry
Investment Outlook 26
5.1 Fastest & Slowest Growing Markets 26
5.2 M&A
Activity Predictions 33
5.3 Supplier’s Industry Outlook 36
6
Recession: Threats & Opportunities For The Drug Manufacturing Industry 40
6.1 Leading Business Concerns Due To Recession 40
6.2 Key Actions To
Overcome Business Threats 44
6.3 Key Actions To Maintain & Win Buyer
Business 48
6.4 Leading Recession-Related Business Opportunities 57
7
Drug Manufacturing Industry Buyer Spend Activity 61
7.1 Annual Procurement
Budgets 61
7.2 Expected Change In Procurement Spend 66
7.3 Expected
Change In Spend By Product & Service Category 70
8 Procurement Behaviors &
Strategies & The Impact Of Recession 78
8.1 Critical Success Factors For
Supplier Selection 78
8.2 Current Effects Of Recession On Procurement
Objectives 84
8.3 Expected Future Effects Of Recession On Procurement
Objectives 88
8.4 The Effects Of Recession On Procurement Strategy 94
9 Appendix 104
9.1 Full Survey Results 104
9.2 Methodology 110
9.3
Contact Us 111
9.4 About Global Markets Direct 111
9.5 Disclaimer
111
1.1 List Of Tables
Table 1: Count Of Global Drug
Manufacturing Industry Survey Respondents By Company Type (Number Of
Respondents), 2009 Industry Survey 11
Table 2: Buyer Respondents By Job
Role (% Buyer Respondents), Global Drug Manufacturing Industry, 2009 12
Table 3: Buyer Respondents By Organization' s Global Turnover (% Buyer
Respondents), Global Drug Manufacturing Industry, 2009 12
Table 4: Buyer
Respondents By Organization' s Total Employee Size (% Buyer Respondents),
Global Drug Manufacturing Industry, 2009 13
Table 5: Supplier Respondents
By Job Role (% Supplier Respondents), Global Drug Manufacturing Industry, 2009
13
Table 6: Supplier Respondents By Organization' s Global Turnover (%
Supplier Respondents), Global Drug Manufacturing Industry, 2009 14
Table
7: Supplier Respondents By Organization' s Total Employee Size (% Supplier
Respondents), Global Drug Manufacturing Industry, 2009 14
Table 8: Global
Drug Manufacturing Industry Expectations Of Global Economy Recovery Timings By
Region: North America, Europe, Asia-Pacific, Rest Of World (% All
Respondents), 2009 20
Table 9: Global Drug Manufacturing Industry
Expectations Of Global Economy Recovery Timings By Company Type: Drug
Manufacturers, Contract Research Organizations / Contract Manufacturing
Organizations, Drug Manufacturing Industry Suppliers (% All Respondents), 2009
21
Table 10: Company Revenue Growth Optimism By Global Drug Manufacturing
Industry Company Type: Drug Manufacturers, Contract Research Organizations /
Contract Manufacturing Organizations, Drug Manufacturing Industry Suppliers (%
All Respondents), 2009 24
Table 11: Company Revenue Growth Optimism In The
Global Drug Manufacturing Industry By Region: North America, Europe,
Asia-Pacific, Rest Of World (% All Respondents), 2009 25
Table 12: Drug
Manufacturer Industry: Market Predictions Of The Fastest And Slowest Growing
Regions (% Drug Manufacturer Respondents), 2009 28
Table 13: Drug
Manufacturing Industry Supplier Industry: Market Predictions Of The Fastest
And Slowest Growing Regions (% Drug Manufacturing Industry Supplier
Respondents), 2009 30
Table 14: Drug Manufacturing Industry Supplier
Industry: Market Predictions Of The Fastest And Slowest Growing Regions (%
Drug Manufacturing Industry Supplier Respondents), 2009 32
Table 15: Key
Growth Areas In The Drug Manufacturing Industry (Analysis Of Supplier
Respondents), 2009 Industry Survey 37
Table 16: Key Growth Areas In The
Drug Manufacturing Industry – Senior Level Responses Only , 2009
Industry Survey 37
Table 17: Key Declining Areas In The Drug Manufacturing
Industry (Analysis Of Supplier Respondents), 2009 Industry Survey 38
Table
18: Key Declining Areas In The Drug Manufacturing Industry – Senior
Level Responses Only , 2009 Industry Survey 39
Table 19: Drug Manufacturer
Vs. Contract Research Organization / Contract Manufacturing Organization Vs.
Drug Manufacturing Industry Supplier: Leading Business Concerns For The Period
2009-2010 Among Global Drug Manufacturing Industry Buyers And Suppliers (% All
Respondents), 2009 43
Table 20: Leading Business Concerns For The Period
2009-2010 Among Global Drug Manufacturing Industry Buyers And Suppliers By
Region: North America, Europe, Asia-Pacific, Rest Of World (% All
Respondents), 2009 44
Table 21: Most Important Actions Being Implemented
By The Drug Manufacturing Industry To Overcome Leading Business Concerns In
2009-2010 (Analysis Of All Respondents), 2009 Industry Survey 45
Table 22:
Most Important Actions Being Implemented By Drug Manufacturing Industry Buyers
To Overcome Leading Business Concerns In 2009-2010 - Senior Level Responses
Only, 2009 Industry Survey 46
Table 23: Most Important Actions Being
Implemented By Drug Manufacturing Industry Buyers To Overcome Leading Business
Concerns In 2009-2010 (Analysis Of Buyer Respondents), 2009 Industry Survey
47
Table 24: Most Important Actions Being Implemented By Drug
Manufacturing Industry Suppliers To Overcome Leading Business Concerns In
2009-2010 (Analysis Of Supplier Respondents), 2009 Industry Survey 48
Table 25: The Most Important Actions For Suppliers To Take To Maintain And
Secure Buyer Business During The Recession In The Global Drug Manufacturing
Industry: Supplier Responses Versus All Buyer Responses (% All Respondents),
2009 50
Table 26: The Most Important Actions For Suppliers To Take To
Maintain And Secure Buyer Business During The Recession In The Global Drug
Manufacturing Industry: Drug Manufacturer Versus Contract Research
Organization / Contract Manufacturing Organization (% Buyer Respondents), 2009
52
Table 27: The Most Important Actions For Suppliers To Take To Maintain
And Secure Buyer Business During The Recession In The Global Drug
Manufacturing Industry: Analysis Of Buyer Respondents By Company Turnover (%
Buyer Respondents), 2009 53
Table 28: The Most Important Actions For
Suppliers To Take To Maintain And Secure Buyer Business During The Recession
In The Global Drug Manufacturing Industry: Analysis Of All Buyer Respondents
By Procurement Budget (% Buyer Respondents), 2009 54
Table 29: The Most
Important Actions For Suppliers To Take To Maintain And Secure Buyer Business
During The Recession In The Global Drug Manufacturing Industry: Analysis Of
All Buyer Respondents By Region (% Buyer Respondents), 2009 56
Table 30:
The Most Important Actions For Suppliers To Take To Maintain And Secure Buyer
Business During The Recession In The Global Drug Manufacturing Industry:
Analysis Of All Buyer Respondents By Purchasing Decision Seniority (% Buyer
Respondents Purchasing Decision Influence), 2009 57
Table 31: Leading
Business Opportunities For The Drug Manufacturing Industry During The
Recession (Analysis Of All Respondents), 2009 Industry Survey 58
Table 32:
Leading Business Opportunities For The Drug Manufacturing Industry During The
Recession – Senior Level Responses Only, 2009 Industry Survey 59
Table 33: Leading Business Opportunities For Drug Manufacturing Industry
Buyers During The Recession (Analysis Of Buyer Respondents), 2009 Industry
Survey 60
Table 34: Leading Business Opportunities For Drug Manufacturing
Industry Suppliers During The Recession (Analysis Of Supplier Respondents),
2009 Industry Survey 60
Table 35: Annual Procurement Budgets In US$ In The
Global Drug Manufacturing Industry: Drug Manufacturer Vs. Contract Research
Organization / Contract Manufacturing Organization (% All Buyer Respondents),
2009 63
Table 36: Annual Procurement Budgets In US$ In The Global Drug
Manufacturing Industry By Region (% All Buyer Respondents), 2009 65
Table
37: Expected Change In Spend On Products & Services In The Global Drug
Manufacturing Industry Over The Next 12 Months: Drug Manufacturer Vs. Contract
Research Organization / Contract Manufacturing Organization (% All Buyer
Respondents), 2009 67
Table 38: Expected Change In Spend On Products &
Services In The Global Drug Manufacturing Industry Over The Next 12 Months By
Region (% All Buyer Respondents), 2009 69
Table 39: Future Change In Spend
In The Global Drug Manufacturing Industry By Product And Service Category:
Expected Increase Or Decrease Over The Next 12 Months Among Drug Manufacturers
(% Drug Manufacturer Respondents), 2009 72
Table 40: Future Change In
Spend In The Global Drug Manufacturing Industry By Product And Service
Category: Expected Increase Or Decrease Over The Next 12 Months Among Contract
Research Organizations / Contract Manufacturing Organizations (% CRO/CMO
Respondents), 2009 74
Table 41: Critical Success Factors For Selecting A
Drug Manufacturing Industry Supplier: Buyer Versus Supplier Comparison (% All
Respondents), 2009 82
Table 42: Critical Success Factors For Selecting A
Drug Manufacturing Industry Supplier: Drug Manufacturer Versus Contract
Research Organization / Contract Manufacturing Organization Comparison (% All
Buyer Respondents), 2009 84
Table 43: Current Effects Of Recession On
Procurement Objectives & Priorities In The Global Drug Manufacturing Industry:
Drug Manufacturer Versus Contract Research Organization / Contract
Manufacturing Organization (% All Buyer Respondents), 2009 87
Table 44:
Current Effects Of Recession On Procurement Objectives & Priorities In The
Global Drug Manufacturing Industry By Company Turnover (% All Buyer
Respondents), 2009 88
Table 45: Expected Changes In Procurement Strategy
In The Global Drug Manufacturing Industry To Drive Value Across The Business
Due To Recession: Drug Manufacturer Versus Contract Research Organization /
Contract Manufacturing Organization (% All Buyer Respondents), 2009 97
Table 46: Expected Changes In Procurement Strategy In The Global Drug
Manufacturing Industry To Drive Value Across The Business Due To Recession:
All Buyers By Company Turnover (% All Buyer Respondents), 2009 98
Table
47: Expected Changes In Procurement Strategy In The Global Drug Manufacturing
Industry To Drive Value Across The Business Due To Recession: All Buyers By
Purchasing Decision Seniority (% All Buyer Respondents Purchasing Decision
Influence), 2009 99
Table 48: Expected Changes In Procurement Strategy In
The Global Drug Manufacturing Industry To Drive Value Across The Business Due
To Recession: All Buyers By Region (% All Respondents), 2009 101
Table 49:
Buyer Attitudes & Approaches To Existing Procurement Practices Among Drug
Manufacturers: Level Of Agreement To The Following 5 Statements (% Drug
Manufacturer Respondents), 2009 102
Table 50: Attitudes & Approaches To
Existing Procurement Practices Among Contract Research Organizations /
Contract Manufacturing Organizations: Level Of Agreement To The Following 5
Statements (% CRO/CMO Respondents), 2010 103
Table 51: Full Survey Results
105
1.2 List Of Figures
Figure 1: Leading Business Concerns For
The Period 2009-2010 Among Global Drug Manufacturing Industry Buyers And
Suppliers (% All Respondents), 2009 16
Figure 2: Global Drug Manufacturing
Industry Expectations Of Global Economy Recovery Timings (% All Respondents),
2009 18
Figure 3: Global Drug Manufacturing Industry Expectations Of
Global Economy Recovery Timings By Region: North America, Europe,
Asia-Pacific, Rest Of World (% All Respondents), 2009 19
Figure 4: Global
Drug Manufacturing Industry Expectations Of Global Economy Recovery Timings By
Company Type: Drug Manufacturers, Contract Research Organizations / Contract
Manufacturing Organizations, Drug Manufacturing Industry Suppliers (% All
Respondents), 2009 21
Figure 5: Company Revenue Growth Optimism In The
Global Drug Manufacturing Industry (% All Respondents), 2009 22
Figure 6:
Company Revenue Growth Optimism By Global Drug Manufacturing Industry Company
Type: Drug Manufacturers, Contract Research Organizations / Contract
Manufacturing Organizations, Drug Manufacturing Industry Suppliers (% All
Respondents), 2009 23
Figure 7: Company Revenue Growth Optimism In The
Global Drug Manufacturing Industry By Region: North America, Europe,
Asia-Pacific, Rest Of World (% All Respondents), 2009 25
Figure 8: Drug
Manufacturer Industry: Market Predictions Of The Fastest And Slowest Growing
Regions (% Drug Manufacturer Respondents), 2009 27
Figure 9: Outsource
Industry (Contract Research Organization / Contract Manufacturing
Organization): Market Predictions Of The Fastest And Slowest Growing Regions
(% Contract Research Organization / Contract Manufacturing Organization
Respondents), 2009 29
Figure 10: Drug Manufacturing Industry Supplier
Industry: Market Predictions Of The Fastest And Slowest Growing Regions (%
Drug Manufacturing Industry Supplier Respondents), 2009 31
Figure 11:
Merger & Acquisition Activity Expectations Over The Next 12 Months In The
Global Drug Manufacturer Industry (% Drug Manufacturer Industry Respondents),
2009 34
Figure 12: Merger & Acquisition Activity Expectations Over The
Next 12 Months In The Global Outsource Industry: Contract Research
Organization / Contract Manufacturing Organization (% Contract Research
Organization / Contract Manufacturing Organization Industry Respondents), 2009
35
Figure 13: Merger & Acquisition Activity Expectations Over The Next 12
Months In The Global Drug Manufacturing Industry Supplier Industry (% Drug
Manufacturing Industry Supplier Industry Respondents), 2009 36
Figure 14:
Leading Business Concerns For The Period 2009-2010 Among Global Drug
Manufacturing Industry Buyers And Suppliers (% All Respondents), 2009 41
Figure 15: Drug Manufacturer Vs. Contract Research Organization / Contract
Manufacturing Organization Vs. Drug Manufacturing Industry Supplier: Leading
Business Concerns For The Period 2009-2010 Among Global Drug Manufacturing
Industry Buyers And Suppliers (% All Respondents), 2009 42
Figure 16: The
Most Important Actions For Suppliers To Take To Maintain And Secure Buyer
Business During The Recession In The Global Drug Manufacturing Industry:
Supplier Responses Versus All Buyer Responses (% All Respondents), 2009 49
Figure 17: The Most Important Actions For Suppliers To Take To Maintain And
Secure Buyer Business During The Recession In The Global Drug Manufacturing
Industry: Drug Manufacturer Versus Contract Research Organization / Contract
Manufacturing Organization (% Buyer Respondents), 2009 51
Figure 18: The
Most Important Actions For Suppliers To Take To Maintain And Secure Buyer
Business During The Recession In The Global Drug Manufacturing Industry:
Analysis Of All Buyer Respondents By Region (% Buyer Respondents), 2009 55
Figure 19: Annual Procurement Budgets In US$ In The Global Drug Manufacturing
Industry: Drug Manufacturer Vs. Contract Research Organization / Contract
Manufacturing Organization (% All Buyer Respondents), 2009 62
Figure 20:
Annual Procurement Budgets In US$ In The Global Drug Manufacturing Industry By
Company Turnover (% All Buyer Respondents), 2009 64
Figure 21: Annual
Procurement Budgets In US$ In The Global Drug Manufacturing Industry By Region
(% All Buyer Respondents), 2009 65
Figure 22: Expected Change In Spend On
Products & Services In The Global Drug Manufacturing Industry Over The Next 12
Months: Drug Manufacturer Vs. Contract Research Organization / Contract
Manufacturing Organization (% All Buyer Respondents), 2009 66
Figure 23:
Expected Change In Spend On Products & Services In The Global Drug
Manufacturing Industry Over The Next 12 Months By Company Turnover (% All
Buyer Respondents), 2009 68
Figure 24: Expected Change In Spend On
Products & Services In The Global Drug Manufacturing Industry Over The Next 12
Months By Region (% All Buyer Respondents), 2009 69
Figure 25: Future
Change In Spend In The Global Drug Manufacturing Industry By Product And
Service Category: Expected Increase Or Decrease Over The Next 12 Months Among
Drug Manufacturers (% Drug Manufacturer Respondents), 2009 71
Figure 26:
Future Change In Spend In The Global Drug Manufacturing Industry By Product
And Service Category: Expected Increase Or Decrease Over The Next 12 Months
Among Contract Research Organizations / Contract Manufacturing Organizations
(% CRO/CMO Respondents), 2009 73
Figure 27: Future Change In Spend In The
Global Drug Manufacturing Industry By Product And Service Category: Expected
Increase Over The Next 12 Months Among Drug Manufacturer Versus Contract
Research Organization / Contract Manufacturing Organization (% All Buyer
Respondents), 2009 75
Figure 28: Future Change In Spend In The Global Drug
Manufacturing Industry By Product And Service Category: Expected Increase Over
The Next 12 Months Among All Buyers By Company Turnover (% All Buyer
Respondents), 2009 76
Figure 29: Future Change In Spend In The Global Drug
Manufacturing Industry By Product And Service Category: Expected Increase Over
The Next 12 Months Among All Buyers By Region (% All Buyer Respondents), 2009
77
Figure 30: Critical Success Factors For Selecting A Drug Manufacturing
Industry Supplier: Difference In Views, Buyers Versus Suppliers (Net
Difference In Ranking), 2009 80
Figure 31: Critical Success Factors For
Selecting A Drug Manufacturing Industry Supplier: Buyer Versus Supplier
Comparison (% All Respondents), 2009 81
Figure 32: Critical Success
Factors For Selecting A Drug Manufacturing Industry Supplier: Drug
Manufacturer Versus Contract Research Organization / Contract Manufacturing
Organization Comparison (% All Buyer Respondents), 2009 83
Figure 33:
Current Effects Of Recession On Procurement Objectives & Priorities In The
Global Drug Manufacturing Industry (% All Buyer Respondents), 2009 85
Figure 34: Current Effects Of Recession On Procurement Objectives & Priorities
In The Global Drug Manufacturing Industry: Drug Manufacturer Versus Contract
Research Organization / Contract Manufacturing Organization (% All Buyer
Respondents), 2009 86
Figure 35: Likelihood Of Future Change In
Procurement Objectives In The Global Drug Manufacturing Industry (% All Buyer
Respondents), 2009 89
Figure 36: Likelihood Of Future Change On
Procurement Objectives In The Global Drug Manufacturing Industry: Drug
Manufacturer Versus Contract Research Organization / Contract Manufacturing
Organization (% All Buyer Respondents), 2009 90
Figure 37: Likelihood Of
Future Change On Procurement Objectives In The Global Drug Manufacturing
Industry By Company Turnover (% All Buyer Respondents), 2009 91
Figure 38:
Expected Future Effects Of Recession On Procurement Objectives & Priorities In
The Global Drug Manufacturing Industry (% All Buyer Respondents), 2009 92
Figure 39: Expected Future Effects Of Recession On Procurement Objectives &
Priorities In The Global Drug Manufacturing Industry: Drug Manufacturer Versus
Contract Research Organization / Contract Manufacturing Organization (% All
Buyer Respondents), 2009 93
Figure 40: Expected Future Effects Of
Recession On Procurement Objectives & Priorities In The Global Drug
Manufacturing Industry By Company Turnover (% All Buyer Respondents), 2009
94
Figure 41: Expected Changes In Procurement Strategy In The Global Drug
Manufacturing Industry To Drive Value Across The Business Due To Recession (%
All Buyer Respondents), 2009 95
Figure 42: Expected Changes In Procurement
Strategy In The Global Drug Manufacturing Industry To Drive Value Across The
Business Due To Recession: Drug Manufacturer Versus Contract Research
Organization / Contract Manufacturing Organization (% All Buyer Respondents),
2009 96
Figure 43: Expected Changes In Procurement Strategy In The Global
Drug Manufacturing Industry To Drive Value Across The Business Due To
Recession: All Buyers By Region (% All Buyer Respondents), 2009 100
|
Related Report
|
View Cart
